NATALIE NOREM: Open Payments
NPI 1881923472 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 13 payments from 7 companies in 2025. Trend: 2023 $413 · 2024 $333 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Amgen Inc. | 3 | $46 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
Products named: GARDASIL 9, SHINGRIX, SAPIEN 3 Ultra RESILIA, EVENITY, Exparel, GVOKE HYPOPEN, AREXVY, CAPVAXIVE.
Industry payments across AZ — which companies pay providers there.
